Fundz

Bambusa Therapeutics Appoints Jonathan I. Lieber as Chief Financial Officer

PUBLIC · BBTXOct 07, 2026

Position

Chief Financial Officer

Company

Bambusa Therapeutics

Jonathan I. Lieber
BostonBiotechnologyHealth CareTherapeutics

Description

Bambusa Therapeutics announces the appointment of Jonathan I. Lieber as Chief Financial Officer. With over 30 years of experience in the biotechnology sector, Jon will contribute to Bambusa's growth and strategic direction.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Bambusa Therapeutics, and when

A new leader at Bambusa Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Bambusa Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bambusa Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bambusa Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bambusa Therapeutics

Location

Boston, Massachusetts, United States

About

Bambusa Therapeutics believes the I&I field is long overdue for innovative approaches and transformative therapeutics. Since our inception, we have built a diverse portfolio of molecules and are uniquely positioned to make significant contributions to patients suffering from debilitating and chronic inflammatory conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bambusa Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Shanshan
Likely contact at this company
••••••••@••••••••

See Shanshan's verified email →

Crystal
Likely contact at this company
••••••••@••••••••

See Crystal's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Bambusa Therapeutics's next move

Learn about Strategic plan

Bambusa Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.